Establishment by enzyme-linked immunosorbent assay of seronegative range for herpes simplex virus and cytomegalovirus antibodies and evaluation of heterologous responses to live varicella vaccine.
Cord serum samples treated with staphylococcus protein A and an immune affinity column to remove immunoglobulin G were used to establish a seronegative range for herpes simplex virus and cytomegalovirus. No seroconversions or increased heterologous antibody levels to herpes simplex virus or cytomegalovirus were found in live varicella vaccine recipients.
Gong
A K
AK
Department of Pediatrics, University of Texas Health Science Center, San Antonio 78284-7812.
Lipton
S V
SV
Brunell
P A
PA
D000328:Adult; D000910:Antibodies, Heterophile / Q000032:analysis / Q000096:biosynthesis*; D000914:Antibodies, Viral / Q000032:analysis* / Q000096:biosynthesis; D019433:Chickenpox Vaccine; D003587:Cytomegalovirus / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay; D005312:Fetal Blood / Q000276:immunology; D014645:Herpesvirus 3, Human / Q000276:immunology; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D018139:Simplexvirus / Q000276:immunology*; D014765:Viral Vaccines / Q000276:immunology*
D000910:Antibodies, Heterophile; D000914:Antibodies, Viral; D019433:Chickenpox Vaccine; D014765:Viral Vaccines